NEW YORK (GenomeWeb) – The China Food and Drug Administration has approved Agilent Technologies' SureScan Dx microarray scanner for in vitro diagnostic use, the company announced today.
The scanner is also CE marked for in vitro diagnostic use in Europe and approved for in vitro diagnostic use in South Korea and Singapore. It measures fluorescence signals from labeled DNA and RNA targets hybridized to microarrays, for example, to compare DNA samples, Agilent said.
Richard Choy, associate professor at the Chinese University of Hong Kong, said in a statement that moving microarray scanning technology to clinical-grade quality standards is needed to bring genome-wide chromosome analysis to the clinic. The SureScan Dx scanner "offers high resolution and sensitivity, as well as dynamic autofocus to correct for differences in slide thickness," he said. "This means high-quality data for analysis."